| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SLC1A5 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | MRPL34 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | ABAT | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | RUNDC3B | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | MYADML2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | SYT6 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | G3BP1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | CSRP2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | ESM1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | FASTKD1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
